Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis

被引：0
|
作者：
Walid Fakhouri
Christophe Sapin
Thorsten Holzkaemper
Inmaculada de la Torre
机构：
[1] Eli Lilly & Company,
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2747 / 2749
页数：2
相关论文
共 50 条
  • [1] Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Fakhouri, Walid
    Sapin, Christophe
    Holzkaemper, Thorsten
    de la Torre, Inmaculada
    ADVANCES IN THERAPY, 2021, 38 (05) : 2747 - 2749
  • [2] Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2021, 38 : 2750 - 2756
  • [3] Authors' Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2021, 38 (05) : 2750 - 2756
  • [4] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2020, 37 : 2356 - 2372
  • [5] Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2020, 37 (05) : 2356 - 2372
  • [6] Comparative Efficacy of Upadacitinib and Other Janus Kinase (JAK) Inhibitors in Patients With Moderate-to-Severe Rheumatoid Arthritis (RA): A Network Meta-analysis (NMA)
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Qi, Cynthia
    Betts, Keith
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1153 - 1153
  • [7] Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis
    Zuo, Yuyue
    Dai, Lei
    Cao, Shiyi
    AUTOIMMUNITY REVIEWS, 2022, 21 (01)
  • [8] Comparative Efficacy and Safety of JAK Inhibitors in the Management of Rheumatoid Arthritis: A Network Meta-Analysis
    Almoallim, Hani M.
    Omair, Mohammed A.
    Ahmed, Sameh A.
    Vidyasagar, Kota
    Sawaf, Bisher
    Yassin, Mohamed A.
    PHARMACEUTICALS, 2025, 18 (02)
  • [9] Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
    Yan, Ting
    Wang, Ting
    Tang, Mei
    Liu, Nan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Efficacy and Safety of JAK Inhibitors for Rheumatoid Arthritis: A Meta-Analysis
    Wang, Faping
    Tang, Xiaoju
    Zhu, Min
    Mao, Hui
    Wan, Huajing
    Luo, Fengming
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
12345